Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aeolus Pharmaceuticals Inc (OTCQB:AOLS)

0.089
Delayed Data
As of Apr 27
 -0.006 / -6.32%
Today’s Change
0.07
Today|||52-Week Range
0.50
-53.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues3.9M9.6M3.1M2.1M
 
 
 
 
 
Depreciation And Amortization6.0K0.000.000.00
 
 
 
Operating ExpensesGross Income--9.6M----
 
 
General Expenses6.6M9.7M5.7M5.3M
 
 
 
 
 
Research And Development3.4M7.0M3.5M2.9M
 
 
 
 
 
Total Operating Expenses6.6M9.7M5.7M5.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-80.0K-2.6M-3.3M
 
 
 
 
 
Extraordinary Charge-510.0K0.000.000.00
 
 
Interest Expense On Debt0.000.002.0K285.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.2M-80.0K-2.6M-3.6M
 
 
 
 
 
Preferred Dividend0.000.000.00-2.5M
 
 
Net Income-3.2M-80.0K-2.6M-3.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS106.6M134.7M135.9M148.7M
 
 
 
 
 
Shares To Calculate EPS Diluted106.6M134.7M135.9M148.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03$0.00-$0.02-$0.04
 
 
 
 
EPS Diluted-$0.03-$0.00-$0.02-$0.04